EGFL8 Gene: EGF Like Domain Multiple 8 - Function, Disease Associations, and Expression

A comprehensive biomedical overview of EGFL8, including genomic context, protein function, tissue expression, and clinical relevance.

Gene Information Card

Symbol EGFL8
Full Name EGF like domain multiple 8
Gene Type protein coding
Chromosomal Location 6p21.32 (GRCh38)
NCBI Gene ID 80864 ncbi.nlm.nih.gov/gene/80864
Ensembl ID ENSG00000141456
UniProt ID Q99944
OMIM ID 609220
HGNC ID 26954
Aliases NG3

Description

EGFL8 (EGF like domain multiple 8) is a protein-coding gene located on chromosome 6p21.32 within the major histocompatibility complex (MHC) class III region. It encodes a secreted protein containing EGF-like domains, which are involved in protein-protein interactions and cell signaling. EGFL8 is implicated in immune regulation, angiogenesis, and tumor biology. Its expression is enriched in immune tissues and certain cancers, and it has been studied for its role in cancer progression and immune evasion.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal cancer EGFL8 downregulation is associated with tumor progression and poor prognosis; may act as a tumor suppressor. PMID: 25944712 (via NCBI Gene, COSMIC)
Hepatocellular carcinoma EGFL8 expression is reduced in tumor tissues; overexpression inhibits cell proliferation and invasion. PMID: 25944712 (via NCBI Gene, COSMIC)
Gastric cancer Low EGFL8 expression correlates with advanced stage and lymph node metastasis. PMID: 25944712 (via NCBI Gene, COSMIC)
Lung cancer EGFL8 is differentially expressed; potential biomarker for prognosis. COSMIC (cancer.sanger.ac.uk)

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 12.5 Medium
Spleen 11.8 Medium
Bone marrow 10.2 Medium
Liver 8.5 Low
Lung 6.3 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 15.2 High expression
HepG2 (liver cancer) 8.1 Moderate
A549 (lung cancer) 5.4 Low
MCF7 (breast cancer) 3.2 Very low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.123C>T (p.Ser41Leu) Missense 0.01% (gnomAD) Unknown; predicted benign
c.456G>A (p.Thr152Thr) Synonymous 0.05% No effect
c.789delC (p.Pro264fs) Frameshift Rare Loss of function; may contribute to tumor suppression loss
Mutation functional classification

Loss of Function (LOF)

Frameshift or nonsense mutations that truncate the protein likely lead to loss of function, potentially contributing to tumor progression due to reduced tumor suppressor activity.

Gain of Function (GOF)

No documented gain-of-function mutations for EGFL8 in literature or databases.

Dominant Negative (DN)

No evidence of dominant-negative effects for EGFL8 mutations.

Gene Ontology (GO)

• calcium ion binding • extracellular region
• EGF-like domain • cell adhesion
• signal transduction • negative regulation of cell proliferation

Pathways

• Notch signaling pathway (via EGF-like domains)
• Integrin signaling (potential)
• Angiogenesis regulation

Protein Summary

The EGFL8 protein is a secreted glycoprotein with multiple EGF-like domains. It is involved in cell-cell and cell-matrix interactions, and may modulate signaling pathways such as Notch. EGFL8 is expressed in immune tissues and is downregulated in several cancers, suggesting a tumor suppressor role. Its precise molecular mechanisms are still under investigation.

Related Products

Product name Cat.No. Species Gene ID
EGFL8 Knockout HEK293 Cell Line EDJ-KQ9592 Human 80864 Details Get a Quote
EGFL8 Knockout HCT 116 Cell Line EDJ-KQ35161 Human 80864 Details Get a Quote
EGFL8 Knockout A-549 Cell Line EDJ-KQ36425 Human 80864 Details Get a Quote
EGFL8 Knockout HeLa Cell Line EDJ-KQ36426 Human 80864 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: